METHODS OF USING THERAPEUTICALLY EFFECTIVE AMOUNT OF ULIPRISTAL OR ANY METABOLITE THEREOF IN DRUG FORMULATION FOR TREATING ENDOMETRIOSIS OR ADENOMYOSIS

摘要

PROBLEM TO BE SOLVED: To provide drug formulation methods for use in reducing or stopping pain and bleeding accompanying so called female genital diseases, more specifically endometriosis or adenomyosis, and for prevention or treatment of anemia in patients.SOLUTION: Disclosed is a method of using a therapeutically effective amount of ulipristal or any ulipristal metabolite in which 5-10 mg or 7-10 mg of ulipristal or optional ulipristal metabolite is used as a therapeutically effective daily dosage.SELECTED DRAWING: None